National Securities Corp analyst Ben Klieve maintained a Buy rating on Yield10 Bioscience (YTEN) today and set a price target of $15.00. The company’s shares closed last Thursday at $5.96.
According to TipRanks.com, Klieve is ranked #1484 out of 7077 analysts.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Yield10 Bioscience with a $20.00 average price target, which is a 236.1% upside from current levels. In a report released today, H.C. Wainwright also maintained a Buy rating on the stock with a $25.00 price target.
See today’s analyst top recommended stocks >>
The company has a one-year high of $14.69 and a one-year low of $3.50. Currently, Yield10 Bioscience has an average volume of 1.21M.
Based on the recent corporate insider activity of 12 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of YTEN in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Yield10 Bioscience, Inc. is an agricultural bioscience company, which focuses on the development of technologies to produce step-change improvements in crop yield for food and feed crops to enhance global food security. The company was founded by Anthony J. Sinskey, Simon F. Williams and Oliver P. Peoples in June 1992 and is headquartered in Woburn, MA.
